INMB INmune Bio Corp Year-over-year net earnings per share growth for the last 12 months
Stable demand for Alzheimer's therapy provides INmune Bio, Inc. (INMB) with macro resilience, which is reflected in the price action when reviewing the quarterly EPS growth index on GURU.Markets. The 29.70 mark indicates the current state of the transition to an innate immunity modulation strategy for cancer treatment. However, the absence of commercial sales makes the capitalization dependent on FDA verdicts, which limits pricing power.
Summary analytical data breakdowns for INmune Bio Corporation (INMB)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital INmune Bio, Inc.|INMB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity INmune Bio, Inc.|INMB - Company Aggregate Debt|Debt to Book Capitalization Ratio INmune Bio Corp|INMB - Company Long-Term Liabilities|Company Current Liabilities INmune Bio|Quick Liquidity inmunebio.com
- earnings and market multiples details:
INMB - Company Profit|Projected Future Earnings INmune Bio, Inc.|INMB - Market Cap to Earnings|Projected Price to Earnings INmune Bio Corp|INMB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple INmune Bio Corp|INMB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) INmune Bio|INMB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months inmunebio.com|INMB - Earnings per share growth rate in current year|Expected earnings per share growth for next year INmune Bio, Inc.
Summary company analysis:INmune Bio, Inc.
This indicator assesses net earnings per share dynamics by comparing quarterly data with the market price to identify stagnation in growth potential. By analyzing the tracking of quarterly EPS growth, an investor determines the risk of value drivers being exhausted, which is critical for INmune Bio, Inc. (INMB) amid costs for the environmental modernization of laboratories and the implementation of energy-saving storage systems.
Main competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BCRX|Year-over-year earnings per share growth for the last twelve months Vera Therapeutics|Year-over-year net earnings per share growth for the last 12 months Dianthus Therapeutics Inc (DNTH)|Year-over-year net earnings per share growth for the last 12 months PHVS (Pharvaris Corp)|Quarterly EPS earnings growth AbCellera Bio (ABCL)|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|PGEN: Year-over-year earnings per share growth for the last 12 months|Pharming Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Year-over-year net earnings per share growth for the last 12 months|Zenas Corp - Year-over-year earnings per one share growth for the last 12 months|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months GOSS|Quarterly EPS earnings growth KALV|Year-over-year net earnings per share change for the last twelve months Septerna, Inc.|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals Inc PVLA|Savara Pharma (SVRA) - Earnings per share growth in annualized terms for the last twelve months|RIGL: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ANAB (anaptysbio.com)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|Year-over-year earnings per share growth for the last 12 months JBIO (Aerovate)|Quarterly EPS earnings growth ACRS|Year-over-year net earnings per share growth for the last 12 months kyvernatx.com KYTX|Tiziana Life Sciences Ltd - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc. (CABA)|Ventyx Bio - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Theratechnologies, Inc THTX|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ELDN|Year-over-year earnings per share growth for the last twelve months Agenus Inc.|Year-over-year net earnings per share growth for the last 12 months Climb Bio Inc. (CLYM)|Quarterly EPS earnings growth ZURA|Year-over-year earnings per share growth for the last twelve months ATYR (aTyr Pharmaceuticals)|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|IMA (ImageneBio) - Year-over-year net earnings per share trend for the last twelve months|Shattuck Therapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months EQ (Equillium, Inc.)|CNTB: Quarterly EPS earnings growth|Immunic (IMUX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|IFRX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months X4 Pharmaceuticals, Inc. (XFOR)|Year-over-year net earnings per share growth for the last 12 months adicetbio.com ACET|Quarterly EPS earnings growth CELU (Celularity)|Quarterly EPS earnings growth Barinthus Biotherapeutics Corp BRNS|KZR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SABS (sabbiotherapeutics.com)|AKTX: Quarterly EPS earnings growth|ENLV - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Q32 Bio Inc|Year-over-year net earnings per share growth for the last 12 months GeoVax Corp (GOVX)|Year-over-year earnings per share growth for the last twelve months Edesa Biotech, Inc. (EDSA)|Year-over-year net earnings per share growth for the last 12 months ibioinc.com IBIO|Carisma Therapeutics Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth XTL Biopharmaceuticals Ltd XTLB|BOLT - Year-over-year earnings per share growth for the last twelve months|HCWB (HCW Biologics Inc.) - Year-over-year earnings per share growth for the last 12 months|APVO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months aimimmuno.com (AIM)|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|GRI Bio Inc (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Vyome Therapeutics - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI - Quarterly EPS earnings growth|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALLK|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months IGM Bio IGMS|Year-over-year net earnings per share growth for the last 12 months ITOS (iTeos Therapeutics, Inc.)|OCEA (Ocean Biomedical Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TCBP (TC BioPharm (Holdings) PLC)|Third Harmonic Bio Inc - Year-over-year earnings per share growth for the last twelve months
